Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours
Soluble Endoglin (CD105) Serum Level as a Potential Marker in the Management of Head and Neck Paragangliomas - Małgorzata Litwiniuk, Kazimierz Niemczyk, Justyna Niderla-Bielińska, Izabela Łukawska-Popieluch, Tomasz Grzela, 2017
PDF] Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma | Semantic Scholar
The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells | Biomedical Research and Therapy